Advances in genomic tools and their decreasing cost are making them more attractive to use in toxic tort claims, reports.

Toxic torts are personal injury lawsuits in which plaintiffs allege that exposure to a chemical or other substance caused them injury to become ill. Most commonly, says these claims are in regards to exposure to chemicals like asbestos, tobacco, or pesticides and cancer development

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.